Kerry has expanded its Carrigaline, County Cork facility to scale industrial production of lactase enzymes for global dairy manufacturing, supporting lactose-free and reduced-sugar product output across international supply chains.

Nutrition Insight reported that Kerry has inaugurated an expanded biotechnology manufacturing facility in Carrigaline, significantly increasing enzyme production capacity for lactose-free and sugar-reduced dairy applications across global markets.

“This investment translates decades of biotech research into scalable, real-world capability,” says Shane McGibney, president and CEO of Biotechnology Solutions and Transformation at Kerry.

The Carrigaline expansion strengthens Kerry’s enzyme platform by linking enzyme engineering and strain development with large-scale manufacturing, enabling faster commercial deployment of dairy biotechnology solutions.

“This facility demonstrates how industry, skills, and innovation come together to support the future of Ireland’s food and biotechnology sectors,” says Peter Burke, Ireland’s minister for Enterprise, Tourism, and Employment.

Lactase enzymes produced at the site are used to process more than two million tons of milk annually, reaching an estimated 28 million global consumers through dairy manufacturing supply chains.

“From our customers perspective this expansion is about execution as much as innovation,” says Ronan Moloney, VP of Enzymes at Kerry.

“With increased manufacturing capacity in Carrigaline combined with application expertise we can support enzyme selection, process optimisation, and scale-up, reducing bottlenecks and strengthening supply continuity as customers commercialise lactose-free and sugar-reduced dairy products,” Moloney added.

The expansion reinforces industrial biotechnology’s role in food manufacturing, supporting scalable enzyme production for global dairy processors responding to rising demand for lactose-free and reduced-sugar products.

Read the full report for details on Kerry’s expanded Carrigaline biotech manufacturing hub and its role in scaling global lactase enzyme production for lactose-free and reduced-sugar dairy manufacturing.